The prognostic role of tertiary lymphoid structure (TLS) in locally advanced esophageal squamous cell carcinoma (ESCC)

被引：1
|
作者：
Huang, Ta-Chen
Liang, Cher-Wei
Li, Yu-I
Guo, Jhe-Cyuan
Lin, Chia-Chi
Lee, Jang-Ming
Chao, Yin-Kai
Hsu, Chih-Hung
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2211
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2211
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic impact of Tertiary lymphoid structures (TLS) surrounding the tumor in esophageal squamous cell carcinoma
    Deguchi, Sota
    Tanaka, Hiroaki
    Mori, Takuya
    Nanbara, Mikio
    Miki, Yuichiro
    Iseki, Yasuhito
    Yoshii, Mami
    Fukuoka, Tatsunari
    Tamura, Tatsuro
    Shibutani, Masatsune
    Nagahara, Hisashi
    Toyokawa, Takahiro
    Lee, Shigeru
    Muguruma, Kazuya
    Ohira, Masaichi
    CANCER SCIENCE, 2021, 112 : 479 - 479
  • [2] Tertiary lymphoid structure associates with poor prognosis in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy
    Huang, Ta-Chen
    Liang, Cher-Wei
    Li, Yu-I
    Guo, Jhe-Cyuan
    Lin, Chia-Chi
    Lee, Jang-Ming
    Chao, Yin-Kai
    Hsu, Chih-Hung
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Neoadjuvant durvalumab plus chemotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC)
    He, J.
    Zhao, L.
    Li, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1553 - S1553
  • [4] A study of neoadjuvant sintilimab combined with chemotherapy TP for locally advanced esophageal squamous cell carcinoma (ESCC).
    Li, Zhao
    Xu, Peng-Fei
    Mao, Wei-Min
    Kuang, YuKang
    Fan, Hai-Yin
    Zou, Bin
    Zhu, Jian-Feng
    Li, Chao
    Cheng, Xiao-Liang
    Liu, Xing-Fei
    Guo, Changying
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16038 - E16038
  • [5] A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC)
    Lee, S.
    Ahn, B. C.
    Park, S. Y.
    Kim, D. J.
    Lee, C. G.
    Cho, J.
    Kim, J. H.
    Kim, H. R.
    Kim, Y-H.
    Park, S. R.
    Chun, Y. J.
    Hong, M. H.
    Kim, H. R.
    Cho, B.
    ANNALS OF ONCOLOGY, 2019, 30
  • [6] A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC).
    Hong, Min Hee
    Kim, HyeRyun
    Park, Seong Yong
    Kim, Dae Joon
    Lee, Chang Geol
    Cho, Jaeho
    Kim, Jong Hoon
    Kim, Hyeong Ryul
    Kim, Yong-Hee
    Park, Sook Ryun
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Neoadjuvant camrelizumab plus docetaxel and carboplatin in locally advanced esophageal squamous cell carcinoma (ESCC): A prospective study
    Wang, R.
    Zhang, G.
    Zhu, Q.
    Ma, T.
    Weng, C.
    Zhang, D.
    Zeng, H.
    Wang, T.
    Gao, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1113 - S1113
  • [8] Camrelizumab combined with albumin paclitaxel and cisplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC).
    Lv, Huilai
    Tian, Yang
    Huang, Chao
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] NEOADJUVANT CAMRELIZUMAB IN COMBINATION WITH ALBUMIN PACLITAXEL AND CISPLATIN FOR PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
    Lv, Huilai
    Tian, Yang
    Li, Zhenhua
    Huang, Chao
    Xu, Yanzhao
    Tian, Ziqiang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A587 - A587
  • [10] Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Nobuhiro Tsuchiya
    Chikara Kunisaki
    Sho Sato
    Yusaku Tanaka
    Kei Sato
    Jun Watanabe
    Kazuhisa Takeda
    Takashi Kosaka
    Hirotoshi Akiyama
    Itaru Endo
    Langenbeck's Archives of Surgery, 2022, 407 : 1911 - 1921
12345